Beijing Tiantan Biological Products Co., Ltd.

Shanghai Stock Exchange 600161.SS

Beijing Tiantan Biological Products Co., Ltd. Net Cash Used Provided By Financing Activities for the year ending December 31, 2023: USD -71.56 M

Beijing Tiantan Biological Products Co., Ltd. Net Cash Used Provided By Financing Activities is USD -71.56 M for the year ending December 31, 2023, a -30.58% change year over year. Net cash used/provided by financing activities are the total cash inflows and outflows related to activities that finance the company’s operations, including debt, equity, and dividends.

Beijing Tiantan Biological Products Co., Ltd. Net Cash Used Provided By Financing Activities for the year ending December 31, 2022 was USD -54.81 M, a -112.55% change year over year.
Beijing Tiantan Biological Products Co., Ltd. Net Cash Used Provided By Financing Activities for the year ending December 31, 2021 was USD 436.63 M, a 1,021.34% change year over year.
Beijing Tiantan Biological Products Co., Ltd. Net Cash Used Provided By Financing Activities for the year ending December 31, 2020 was USD 38.94 M, a 212.12% change year over year.
Beijing Tiantan Biological Products Co., Ltd. Net Cash Used Provided By Financing Activities for the year ending December 31, 2019 was USD 12.48 M, a 108.32% change year over year.

Key data

Date	Net Cash Used Provided By Financing Activities	Dividends Paid	Capital Expenditure	Effect Of Forex Changes On Cash

Shanghai Stock Exchange: 600161.SS

Beijing Tiantan Biological Products Co., Ltd.

CEO	Mr. Dao Xing Fu
IPO Date	June 16, 1998
Location	China
Headquarters	No. 2 Courtyard
Employees	4,858
Sector	Health Care
Industries Biotechnology Pharmaceuticals

Description

Beijing Tiantan Biological Products Co., Ltd. engages in the research and development, manufacture, sale, and consulting of blood products in China. Its products include blood intravenous injection immunoglobulin; blood human albumin; blood system intravenous injection; hepatitis B, freeze-dried hepatitis B, and tetanus human immunoglobulin; human immunoglobulin; and other blood products. The company was incorporated in 1998 and is headquartered in Beijing, China. Beijing Tiantan Biological Products Co., Ltd. operates as a subsidiary of China National Biotec Group Company Limited.

Key trends

Past 5 years